fbpx Skip to content

Don't Wait to Diagnose AMD

How many of your patients have undetected AMD?

AMD is the leading cause of blindness in the US. Eye care professionals who test for impaired dark adaptation speed can confirm that the studies are true: clinical AMD is more prevalent than glaucoma and diabetic retinopathy combined.

Prevalence Graphic of AMD and other eye diseases


How Many AMD Patients Are in Your Practice?

Let’s do the math. Enter your information below to estimate how many of your patients can benefit from earlier AMD detection.


The AdaptDx Pro gives us the opportunity to change the future of macular degeneration care because it allows us to screen everyone at risk and identify macular degeneration earlier. The whole objective is to reduce the number of patients losing vision from macular degeneration.

RyanPowell Ryan Powell, OD View all testimonials

AdaptDx Pro Testing Can Help Improve Patient Outcomes

The AdaptDx Pro® is a simple, fully automated dark adaptometer. It measures dark adaptation speed, which can be used to identify AMD with 90% sensitivity.

Integrate AdaptDx Pro into Your Practice through our AMD Excellence Program

We learned that the simplest way to optimize results for your patients and your practice is to make dark adaptation testing part of the standard workup based on the leading risk factor for the disease: age. This new standard of AMD care provides consistency for your patients and your practice, generating better outcomes for both.

Every AdaptDx Pro subscription is supported by our AMD Excellence Program® which will put your team on the path to success. Are you ready to join your colleagues in capturing and managing AMD?